P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; pp. 280 - 281
Main Authors Aakko, S., Ylitalo, A., Kuusanmäki, H., Björkman, M., Mandelin, J., Jalkanen, J., Fjällskog, M.‐L., Heckman, C., Hollmén, M., Kontro, M.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 01.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000844408.27334.5c